Cargando…
Clinical Grade Production of Wilms’ Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation
Hematopoietic cell transplantation (HCT) is a last resort, potentially curative treatment option for pediatric patients with refractory acute myeloid leukemia (AML). Cord blood transplantation (CBT) results in less relapses and less graft-versus-host disease when compared to other sources. Neverthel...
Autores principales: | Plantinga, Maud, Lo Presti, Vania, de Haar, Colin G., Dünnebach, Ester, Madrigal, Alejandro, Lindemans, Caroline A., Boelens, Jaap Jan, Nierkens, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546401/ https://www.ncbi.nlm.nih.gov/pubmed/33101274 http://dx.doi.org/10.3389/fimmu.2020.559152 |
Ejemplares similares
-
Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination
por: de Haar, Colin, et al.
Publicado: (2013) -
Efficient lentiviral transduction method to gene modify cord blood CD8(+) T cells for cancer therapy applications
por: Lo Presti, Vania, et al.
Publicado: (2021) -
Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors
por: Plantinga, Maud, et al.
Publicado: (2019) -
Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
por: Plantinga, Maud, et al.
Publicado: (2014) -
CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine
por: Plantinga, Maud, et al.
Publicado: (2021)